| Literature DB >> 24673894 |
Hiroko Inoue, Ryosuke Sasaki, Izumi Aiso, Toshiko Kuwano1.
Abstract
BACKGROUND: Metabolic syndrome is now widely appreciated as a cluster of metabolic abnormalities such as visceral obesity, hypertension, hyperglycemia and dyslipidemia. To date, incidence of metabolic syndrome is continuously increasing worldwide.In addition, low vegetable consumption has recently become a serious issue in Japan. Furthermore, Japan is facing a shortfall in places offering food that can help prevent metabolic syndrome in the first place. Our study is designed to influence these developments. We conducted a non-randomized controlled trial by offering a Japanese-style healthy lunch menu to middle-aged men in a workplace cafeteria. This menu was designed to prevent and reduce metabolic syndrome.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24673894 PMCID: PMC3986820 DOI: 10.1186/1476-511X-13-57
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Figure 1Flow diagram of study participants. Participants were non-randomized when assigned to the control or intervention group. We chose not to use medicine as criteria of participant recruitment. We chose not to consider taking medicine for fat or carbohydrate metabolism as exclusion criteria. We excluded data of participants who left in the middle of the study. Data of 35 males were finally analyzed.
Baseline characteristics of participants
| Age (y)* | 42.1 ± 4.5 | 48.5 ± 8.1 | 0.013 | 47.2 ± 7.9 |
| Height (cm)* | 174.3 ± 4.4 | 168.0 ± 5.8 | 0.012 | 169.3 ± 6.0 |
| Weight (kg)† | 70.4 ± 13.1 | 71.8 ± 11.3 | 0.773 | 71.5 ± 11.5 |
| BMI (kg/m2)* | 23.1 ± 3.9 | 25.4 ± 3.3 | 0.130 | 24.9 ± 3.5 |
| BFP (%)† | 23.6 ± 6.5 | 26.1 ± 5.8 | 0.208 | 25.6 ± 5.9 |
| SBP (mmHg)† | 127.3 ± 10.0 | 138.8 ± 14.1 | 0.117 | 136.5 ± 14.0 |
| DBP (mmHg)* | 81.3 ± 7.4 | 89.3 ± 11.0 | 0.080 | 87.7 ± 10.8 |
| Waist Circumference (cm)* | 85.2 ± 11.6 | 88.3 ± 9.2 | 0.449 | 87.7 ± 9.7 |
| T-Chol (mg/dL)* | 185 ± 32 | 215 ± 27 | 0.014 | 209 ± 30 |
| LDL-Chol (mg/dL)† | 105 ± 44 | 131 ± 31 | 0.194 | 126 ± 35 |
| HDL-Chol (mg/dL)* | 49 ± 17 | 56 ± 10 | 0.157 | 55 ± 12 |
| Triacylglycerol (mg/dL)† | 240 ± 374 | 158 ± 95 | 0.343 | 175 ± 182 |
| Glucose (mg/dL)† | 114 ± 18 | 114 ± 24 | 0.805 | 114 ± 23 |
| Hemoglobin A1C (%)† | 5.0 ± 0.3 | 5.4 ± 0.7 | 0.120 | 5.3 ± 0.6 |
| Active ghrelin (fmol/mL)† | 3.5 ± 5.7 | 1.7 ± 4.6 | 0.614 | 2.0 ± 4.8 |
| Desacyl ghrelin (fmol/mL)† | 133.2 ± 161.2 | 62.0 ± 107.2 | 0.331 | 76.3 ± 120.6 |
| Leptin (pg/mL)† | 1692 ± 1903 | 2574 ± 2134 | 0.201 | 2398 ± 2093 |
| Energy (kcal)* | 2206 ± 473 | 2188 ± 556 | 0.937 | 2191 ± 534 |
| Protein (g)* | 75.6 ± 14.9 | 76.8 ± 23.0 | 0.892 | 76.6 ± 21.4 |
| Fat (g)* | 64.7 ± 15.0 | 67.1 ± 23.5 | 0.792 | 66.6 ± 21.9 |
| Carbohydrate (g)* | 310.2 ± 122.8 | 308.6 ± 93.1 | 0.969 | 308.9 ± 97.7 |
| Salt (g)* | 11.3 ± 3.3 | 12.0 ± 3.8 | 0.648 | 11.9 ± 3.7 |
| Soluble dietary fiber (g)† | 3.0 ± 0.7 | 3.4 ± 1.6 | 0.680 | 3.4 ± 1.5 |
| Insoluble dietary fiber (g)* | 12.0 ± 3.0 | 11.1 ± 4.0 | 0.599 | 11.3 ± 3.8 |
| Total dietary fiber (g)* | 16.7 ± 6.4 | 15.9 ± 7.0 | 0.256 | 16.0 ± 6.8 |
| Green and yellow vegetable (g)† | 115.0 ± 102.0 | 92.0 ± 74.0 | 0.726 | 96.6 ± 79.2 |
| Other vegetable (g)* | 240.1 ± 128.5 | 182.1 ± 119.8 | 0.267 | 193.7 ± 121.9 |
| Total vegetable (g)* | 355.1 ± 156.1 | 274.1 ± 168.1 | 0.256 | 290.3 ± 166.8 |
Data shows mean ± S.D.
Abbreviations: BMI Body mass index, BFP Body fat percentage, SBP Systolic blood pressure, DBP diastolic blood pressure, T-Chol Total cholesterol, LDL-Chol Low-density lipoprotein cholesterol, HDL-Chol high-density lipoprotein cholesterol.
*p stands for the difference between the control and intervention groups at baseline parameters analyzed by the independent sample t test. †p stands for the difference between the control and intervention groups at baseline parameters analyzed by the Mann–Whitney test.
Difference was considered significant at p < 0.05.
Changes in anthropometric data
| | | | |||||
|---|---|---|---|---|---|---|---|
| | Baseline | 70.4 ± 13.1 | | 77.2 ± 13.9 | | 67.8 ± 7.0 | |
| Weight (kg) | | | 0.132* | | 0.546* | | 0.330† |
| | After 3 months | 71.5 ± 12.8 | | 77.5 ± 13.5 | | 67.4 ± 6.9 | |
| | Baseline | 23.1 ± 3.9 | | 27.2 ± 3.4 | | 24.0 ± 2.4 | |
| BMI (kg/m2) | | | 0.175* | | 0.618* | | 0.210* |
| | After 3 months | 23.4 ± 3.8 | | 27.3 ± 3.2 | | 23.8 ± 2.5 | |
| | Baseline | 23.6 ± 6.5 | | 29.1 ± 6.9 | | 23.8 ± 3.5 | |
| BFP (%) | | | 0.126* | | 0.783† | | 0.019* |
| | After 3 months | 24.1 ± 6.8 | | 29.0 ± 7.2 | | 22.7 ± 3.6 | |
| | Baseline | 127.3 ± 10.0 | | 140.5 ± 13.1 | | 137.5 ± 15.0 | |
| SBP (mmHg) | | | 0.063* | | 0.277* | | 0.023† |
| | After 3 months | 132.4 ± 10.8 | | 138.1 ± 14.9 | | 131.9 ± 16.9 | |
| | Baseline | 81.3 ± 7.4 | | 90.5 ± 11.9 | | 88.4 ± 10.6 | |
| DBP (mmHg) | | | 0.506* | | 0.000* | | 0.001* |
| | After 3 months | 80.3 ± 7.4 | | 86.3 ± 11.4 | | 80.8 ± 8.7 | |
| | Baseline | 85.2 ± 11.6 | | 91.8 ± 10.8 | | 85.7 ± 7.1 | |
| WC (cm) | | | 0.861* | | 0.307* | | 0.129* |
| After 3 months | 85.0 ± 13.2 | 91.0 ± 10.9 | 84.8 ± 7.4 | ||||
Data shows mean ± S.D.
Abbreviations: BMI Body mass index, BFP Body fat percentage, SBP Systolic blood pressure, DBP Diastolic blood pressure, WC Waist circumference.
*p stands for the difference between the baseline parameters and the parameters after 3 months analyzed by the paired t-test.
†p stands for the difference between the baseline parameters and the parameters after 3 months analyzed by Wilcoxon’s signed rank test.
Difference was considered significant at p < 0.05.
Change in blood parameters
| | | | |||||
|---|---|---|---|---|---|---|---|
| | Baseline | 185 ± 32 | | 222 ± 26 | | 211 ± 27 | |
| T-Chol (mg/dL) | | | 0.191* | | 0.229* | | 0.006* |
| | After 3 months | 199 ± 40 | | 215 ± 28 | | 199 ± 22 | |
| | Baseline | 105 ± 44 | | 136 ± 30 | | 127 ± 31 | |
| LDL-Chol (mg/dL) | | | 0.292* | | 0.437* | | 0.010* |
| | After 3 months | 109 ± 45 | | 132 ± 26 | | 116 ± 25 | |
| | Baseline | 49 ± 17 | | 53 ± 7 | | 59 ± 11 | |
| HDL-Chol (mg/dL) | | | 0.522* | | 0.287* | | 0.073* |
| | After 3 months | 49 ± 16 | | 51 ± 8 | | 56 ± 15 | |
| | Baseline | 240 ± 374 | | 208 ± 116 | | 121 ± 55 | |
| Triacylglycerol (mg/dL) | | | 0.173† | | 0.136† | | 0.408† |
| | After 3 months | 289 ± 436 | | 181 ± 67 | | 115 ± 51 | |
| | Baseline | 113 ± 18 | | 108 ± 19 | | 118 ± 28 | |
| Glucose (mg/dL) | | | 0.735† | | 0.583† | | 0.255† |
| | After 3 months | 112 ± 21 | | 107 ± 16 | | 111 ± 18 | |
| | Baseline | 5.0 ± 0.3 | | 5.3 ± 0.5 | | 5.5 ± 0.8 | |
| Hemoglobin A1C (%) | | | 0.041† | | 0.033† | | 0.529† |
| | After 3 months | 5.1 ± 0.2 | | 5.4 ± 0.5 | | 5.5 ± 0.7 | |
| | Baseline | 3.5 ± 5.7 | | 1.4 ± 2.0 | | 1.9 ± 5.9 | |
| Active ghrelin (fmol/mL) | | | 0.128† | | 0.008† | | .001† |
| | After 3 months | 6.4 ± 7.4 | | 3.8 ± 3.9 | | 5.3 ± 8.4 | |
| | Baseline | 133.2 ± 161.2 | | 41.6 ± 49.0 | | 77.4 ± 135.4 | |
| Desacyl ghrelin (fmol/mL) | | | 1.000† | | 0.002† | | 0.001† |
| | After 3 months | 108.0 ± 67.7 | | 101.4 ± 89.3 | | 115.7 ± 180.7 | |
| | Baseline | 1692 ± 1903 | | 3611 ± 2786 | | 1797 ± 999 | |
| Leptin (pg/mL) | | | 0.074* | | 0.001* | | 0.000† |
| After 3 months | 308 ± 219 | 610 ± 391 | 313 ± 158 | ||||
Data shows mean ± S.D. Abbreviations: T-Chol Total cholesterol, LDL-Chol Low-density lipoprotein cholesterol, HDL-Chol high-density lipoprotein cholesterol. *p stands for the difference between the baseline parameters and the parameters after 3 months analyzed by the paired t-test. †p stands for the difference between the baseline parameters and the parameters after 3 months analyzed by Wilcoxon’s signed rank test. Difference was considered significant at p < 0.05.
Changes in dietary intake
| | | | | | |||
|---|---|---|---|---|---|---|---|
| | Baseline | 2206 ± 473 | | 2554 ± 392 | | 1938 ± 517 | |
| Energy (kcal) | | | 0.336 | | 0.042 | | 0.543 |
| | After 3 months | 2423 ± 548 | | 2104 ± 393 | | 2040 ± 403 | |
| | Baseline | 75.6 ± 14.9 | | 86.4 ± 23.1 | | 68.2 ± 21.0 | |
| Protein (g) | | | 0.266 | | 0.765 | | 0.028 |
| | After 3 months | 84.4 ± 13.6 | | 82.9 ± 25.6 | | 90.9 ± 30.0 | |
| | Baseline | 64.7 ± 15.0 | | 78.8 ± 19.4 | | 55.7 ± 15.5 | |
| Fat (g) | | | 0.774 | | 0.151 | | 0.286 |
| | After 3 months | 68.3 ± 31.2 | | 59.5 ± 24.7 | | 49.1 ± 13.1 | |
| | Baseline | 310.2 ± 122.8 | | 359.6 ± 85.2 | | 284.8 ± 91.3 | |
| Carbohydrate (g) | | | 0.286 | | 0.049 | | 0.386 |
| | After 3 months | 345.2 ± 116.2 | | 295.8 ± 45.3 | | 308.1 ± 66.1 | |
| | Baseline | 11.3 ± 3.3 | | 12.8 ± 4.1 | | 11.2 ± 4.0 | |
| Salt (g) | | | 0.823 | | 0.723 | | 0.426 |
| | After 3 months | 11.6 ± 2.3 | | 12.2 ± 5.0 | | 12.5 ± 5.3 | |
| | Baseline | 16.7 ± 6.4 | | 18.2 ± 9.0 | | 15.3 ± 5.2 | |
| Total dietary fiber (g) | | | 0.912 | | 0.661 | | 0.047 |
| | After 3 months | 17.1 ± 7.7 | | 20.8 ± 14.9 | | 30.4 ± 20.9 | |
| | Baseline | 355.1 ± 156.1 | | 298.4 ± 203.5 | | 292.4 ± 146.6 | |
| Total vegetables (g) | | | 0.210 | | 0.232 | | 0.035 |
| After 3 months | 273.8 ± 152.2 | 211.0 ± 110.0 | 411.1 ± 155.9 | ||||
Data shows mean ± S.D.
p stands for the difference between the baseline parameters and the parameters after 3 months analyzed by the paired t-test.
Difference was considered significant at p < 0.05.